'Not As Easy' OTC Codeine Label Changes Worry FDA Rx Product Advisors
This article was originally published in The Pink Sheet
Executive Summary
FDA officials acknowledge at the Pediatric Advisory Committee Sept. 11 that labeling restrictions for opioid-containing Rx antitussives for pediatric cough wouldn't apply to labeling for codeine cough products available under an OTC monograph.